James Sapirstein, Chairman and CEO at Entero Therapeutics, Inc. (ENTO), sold 1,289 shares at $1.07 ($1K) on 2024-07-02, disclosed to the SEC on 2024-07-03.
Open-market sale of $1k ENTO by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| FWBI | SELL | 2024-01-17 | $697 | — | Filing → |
| FWBI | SELL | 2023-10-06 | $802 | — | Filing → |
| FWBI | SELL | 2023-07-05 | $5K | — | Filing → |